Application Nr Approved Date Route Status External Links
ANDA090430 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Theophylline Extended-Release Tablets Are Indicated For The Treatment Of The Symptoms And Reversible Airflow Obstruction Associated With Chronic Asthma And Other Chronic Lung Diseases, E.g., Emphysema And Chronic Bronchitis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Theophylline Anhydrous THEOPHYLLINE ANHYDROUS ZINC18043251

Comments